Pulling SEC filings + quote and writing the call…

GeoVax Labs, Inc.
Next earnings Jul 27, 2026 · consensus $-2.94 EPS
Last earnings -3.1% on 2026-05-14
Conservative balance sheet (liabilities/equity 0.66x); but revenue fell -37.1% YoY.
GeoVax Labs, Inc. shows $2.49M in FY2025 revenue (-37.1% YoY), a -862.3% net margin, and -561.2% ROE.
Sources: SEC EDGAR (CIK 0000832489, latest 10-Q filed 2026-05-14) · EODHD · as of 6/22/2026, 9:46:23 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $386K | $81.5K | $0.00 | $3.95M | $2.49M |
| Gross profit | — | — | — | — | — |
| Operating income | -$18.7M | -$14.0M | -$26.7M | -$25.1M | -$21.6M |
| Net income | -$18.6M | -$14.0M | -$26.0M | -$25.0M | -$21.5M |
| Diluted EPS | -$3.04 | — | — | — | — |
| Net margin | -4817.2% | -17198.3% | — | -632.0% | -862.3% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1072 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.